Stephen J. Galli's most recent trade in Atossa Therapeutics Inc was a trade of 10,000 Common Stock done . Disclosure was reported to the exchange on May 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atossa Therapeutics Inc | Stephen J. Galli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2026 | 10,000 | 10,006 (0%) | 0% | 0 | Common Stock | |
| Atossa Therapeutics Inc | Stephen J. Galli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Atossa Therapeutics Inc | Stephen J. Galli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Atossa Therapeutics Inc | Stephen J. Galli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) |